Olema Oncology is headquartered in San Francisco, California.
Olema Oncology disclosed revenue of 105M USD for 2023 and 107M USD for 2022.
Olema Oncology has 116 employees.
Olema Oncology is a life science company.
Olema Oncology was founded in 2006.
780 Brannan Street,
San Francisco, California
94103
United States,
(415) 651-3316
www.olema.com
Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. The company's lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalation and expansion clinical trial of OP-1250. Olema Oncology was formed in 2006 and is based in San Francisco, California.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
